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Abstract
The Appalachian region of the United States has a high prevalence of diabetes, placing
residents with diabetes at risk for physical, psychological, social, and financial burdens.
To compound the issue, primary care providers often do not adhere to the guidelines
established by the American Diabetes Association (ADA) regarding the recommended
frequency of testing hemoglobin A1C in patients with diabetes. Lewin’s planned change
theory guided the project. The purpose of this project was to measure the knowledge of
the primary care providers before and after an educational intervention covering the ADA
guidelines for A1C monitoring and testing and to assess compliance with the guideline.
The 12 volunteer participants were medical doctors, physician assistants and family nurse
practitioners who served as primary care providers for a rural health clinic. Results of the
educational presentation and the pre- and posttests indicated that providers improved in
their knowledge of the ADA guidelines for prevention and management of diabetes.
Providers identified 9 reasons that patients were not compliant with follow-up for A1C
monitoring, including lack of provider knowledge of the guidelines, distance to travel to
the clinic, delayed lab results, forgetting to keep appointments, bad weather, no
transportation, lost orders for labs, fear that the A1C will be elevated, and fear of having
more medications added to their treatment plan. This project has the potential to promote
positive social change by raising awareness among providers of the need for regular
monitoring of hemoglobin A1C and following the ADA guidelines for the treatment and
management of diabetes. In so doing, the project may reduce the complications of
diabetes for patients in the community.
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Section 1: Nature of the Project
Hemoglobin A1C History for Testing and Treatment
The glycosylated hemoglobin A1C (A1C) test is a blood test that provides
information about the patient’s average levels of blood glucose over the past 3 months.
The test is based on the attachment of glucose hemoglobin, with a normal A1C level
being below 5.7% (Koenig et al, 1976). Since its discovery, researchers have determined
that one component, A1C, was observed to be elevated in diabetic patients (Koenig et al.,
1976). The valuable knowledge of the elevated A1C component has guided researchers
to the realization it could be used in the treatment or diagnosis of diabetes mellitus (DM).
In 1984, the additional knowledge of the A1C assay enhanced the use of A1C as
an effective evaluation tool for the primary care provider (PCP), specifically for the
evaluation of long-term glucose levels in diabetic patients (Little & Rohlfing, 2013). The
challenge of using the A1C as a clinical evaluation tool is the lack of clinical guidelines;
no central reference, laboratory data, or conclusive and accurate values as a reliable
reference range available for clinical practice use and implementation (Little & Rohlfing,
2013).
The National Institute of Diabetes and Digestive and Kidney Diseases, a division
of the National Institute of Health, conducted The Diabetes Control and Complications
Trial from 1983 to 1993 of 1,441 patients with DM. The Diabetes Control and
Complications Trial (1983 to 1993) determined the significance of keeping the patient’s
A1C to a level of 6%, drastically reducing risks of renal, cardiovascular, ophthalmologic,
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and neurological systems. In 2013, Epidemiology of Diabetes Interventions and
Complications continued with a follow up study that tracked the majority of the
participants in the original study. The participants who kept their A1C levels between 6
and 7% had a decrease in the risk of cardiovascular complications (Lenters-Westra et al,
2013).
Incorporation of Hemoglobin A1C Into Clinical Practice
The American Diabetes Association (ADA; 1997) first introduced the A1C
parameters into their standard of medical care in 1997. The most up-to-date standard for
medical practice for A1C testing and DM management was published in 2013and was
considered to be the gold standard for the best possible patient care (ADA, 2013). The
use in clinical practice includes diagnosing, screening, evaluation, and adjustment of diet
and medications (ADA, 2013). The A1C test normal range is 5.5% to 7.0% and
measures a daily average of the previous 90 to 120 days for the amount of glucose that
comes into contact red blood cell hemoglobin molecules (ADA, 2013). The testing for
the A1C in clinical practice is recommended to be done every 6 months (semiannually)
for patients who are stable < 7.0%, as per ADA guideline suggestions; if ≥ 7%, the A1C
should be done every 3 months (quarterly) (ADA, 2013).
Significance of Diabetes in the United States
Diabetes is the seventh leading cause of death in the United States, according to
the Centers for Disease Control and Prevention (CDC). In people with diabetes, the
leading cause of death is contributed to cardiovascular disease; it is estimated that 68% of
diabetics die of stroke or heart disease in the United States (CDC, 2011). Overall, the
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diabetic population death risk is double of people without having diabetes (Centers for
Disease Control and Prevention [CDC], 2011). It is estimated that 230,000 Americans
die each year from complications of diabetes, according to the National Institute of
Diabetes and Digestive and Kidney Diseases (U.S. Department of Health and Human
Services, National Institutes of Health, National Institute of Diabetes, and Digestive and
Kidney Diseases, 2011).
In 2011, there were approximately 26 million people diagnosed with diabetes in
the United States (CDC, 2011). The estimated total health care cost of diabetes is $174
billion annually; broken down, the direct medical cost including treatment supplies,
medical care, and hospitalizations account for an estimate of $116 billion (CDC, 2011).
The indirect covers cost such as time lost from work, disability payments, and premature
death is estimated to be about $58 billion (CDC, 2011). DM can lead to complications of
cardiovascular disease, hypertension, stroke, kidney disease, amputations, and blindness
(Diabetes Basics, 2013).
Significance of Diabetes in West Virginia
The Appalachian Region became as an entity by the federal government in 1969.
It covers about 110,000 square miles in the states of Maryland, Virginia, West Virginia,
Kentucky, Tennessee, North and South Carolina, and Georgia. The population of the
Appalachian Mountain Chain is approximately 24.8 million people, with 42% of the
population living in rural areas, including the entire state of West Virginia (WV) (The
Appalachian Community, 2012). Geographically isolated throughout much of their
history, the people of Appalachia are thought to have retained cultural traditions of the
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early 19th century (The Appalachian Community, 2012). Lagging behind the United
States, Appalachia continues to fall behind on social and economic indicators (The
Appalachian Community, 2012). Thus, long-standing poverty and accompanying
stresses continue to threaten the health of the people living in this region (The
Appalachian Community, 2012).
Diseases and comorbid conditions such as diabetes, stroke, cardiac, cancer, and
other associated health conditions and risks are frequently as high for many living in
Appalachia as for other groups considered to be of national minority (The Appalachian
Community, 2012). Recent population statistics for WV in November 2013 show that
about 1 in 8 adults in WV have diabetes (The Appalachian Community, 2012). The most
recent statistics for WV show the state to have between the second and fourth highest
population of people to have diabetes in the country (Goss, 2013).
WV is federally designated as a Primary Care Health Professional Shortage Area
(U.S. Department of Health and Human Services, 2013). More specifically, in rural WV,
the problem of inadequate diabetes management is worsened by the absence of
endocrinologists to provide specialized care to the diabetic patients in those rural areas
(U.S. Department of Health and Human Services, 2013). The nearest endocrinologist
specialist is sometimes two hours away. There are many people who do not own a
vehicle or have reliable transportation to drive the required distance to the
endocrinologist for diabetes monitoring or management (U.S. Department of Health and
Human Services, 2013). Thus, it is imperative for providers to follow recommended
guidelines in order to maximize patient outcomes.
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Diabetes has been monitored in WV through surveillance and statistic centers.
Through this monitoring, facts about health equity and the social determinants of health
in rural areas of WV were discovered. The reports through the Department of Health and
Human Resources revealed that people with diabetes make less money and have less
education. Counties with higher diabetes prevalence, also had lower income levels and
more people with diabetes who were unable to work. There is a higher prevalence of
people with diabetes who report they have an impairment that limits their activities, and
people with diabetes have higher levels of life dissatisfaction (Stohr, 2012). Northcentral
WV, during the years 2006 to 2010, had a low prevalence of DM at 7.9%. Higher levels
of diabetes prevalence in the same report was in southern WV at 17.7% (Stohr, 2012).
In 2010, Novo Nordisck Pharmtech comissioned a comparison to be made for the
years of 2010, 2015, and 2025 with statistics and projected percentages for people with
diabetes in WV. In 2010, the approximate number of people living with diabetes was
268,554, with a prevalence of 14.68% of the state population of people living with
diagnosed or undiagnosed diabetes (Changing Diabetes Barometer, 2014). In 2015, the
approximate projected number of people living with diabetes was expected to be 290,113,
with a projected prevalence of 15.92% of people living with diabetes(Changing Diabetes
Barometer, 2014).
By 2025, the projected number of the people living with diabetes is expected to be
314,864, with a projected prevalence of 17.82% of people to be living with diabetes in
WV (Changing Diabetes Barometer, 2014). According to Novo Nordisck Pharmtech’s
current and projected statistics, it is important to keep track of the population who is at
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risk or who have diabetes, the kinds of management provided, such as monitoring the
frequency of testing the A1C, and the results that are to be achieved.
Facts about the Appalachian rural clinics include the diagnosis prevalence rates
among adults. According to the CDC (2011), in rural WV, the prevalence rate was in the
high range (12.1–21.6%). According to the Institute for Alternative Futures, the
estimated prevalence rates for 2015 was approximately 194,400 with diagnosed diabetes,
another 95,700 with Type 2 diabetes that remained undiagnosed, and an additional
464,300 who had prediabetes (Changing Diabetes Barometer, 2014).
Problem Statement
Despite the standards of practice, diabetes continues to be a concern in the United
States. Over 28 million people are being treated for the disease and treatment, costing
245 billion per year (Statistics About Diabetes, 2014). The use of ADA clinical practice
standards and guidelines by the PCP can enhance the quality of care and patient outcomes
for individuals with diabetes. However, the PCP practice problem can be a result of selfefficacy and lack of confidence in ability, leading to clinical inertia (Shaefer, 2006).
Purpose Statement
The purpose of the Doctor of Nursing Practice (DNP) project staff education is to
measure the knowledge of PCPs from an educational intervention regarding the
recommended ADA guidelines for A1C patient monitoring and testing.
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Project Objectives
The objective of this DNP staff education project is to increase the knowledge of
the ADA guidelines for A1C patient monitoring and testing among PCP in Appalachian
rural clinics.
Project Question
Is there a difference in knowledge following an educational intervention regarding
the ADA guidelines for A1C patient monitoring and testing among PCP in Appalachian
rural clinics?
Evidence of Problem
The specific identified practice problem is the frequency of testing of the A1C in
the Appalachian rural clinics. According to the ADA guidelines, routine monitoring of
glycemic control using A1C by providers in clinic practice is often not completed during
routine office visits (Egbunike & Gerald, 2013). Eighty percent of patients in the first
year after diagnosis with diabetes do not have testing for A1C measurements during their
office visits (Egbunike & Gerald, 2013).
Strategies and tools such as electronic chart provider reminders for testing of
A1Cs are underused in the rural clinics. In order to provide safe, effective, and quality
care to the patients in the Appalachian rural clinics for prevention, diagnosing, and
monitoring of diabetes, it is imperative to have tools and strategies in place to educate,
remind, and ensure the PCPs follow the ADA guidelines.
The PCP in the Appalachian rural clinics should adhere to the recommended
frequency for doing A1C testing, according to the ADA guidelines for diagnosing and
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management of Type 2 diabetes. Monitoring by obtaining the A1C at regular intervals in
the rural clinic helps to provide the diabetic patient with safe and effective care that has
optimal outcomes (Egbunike & Gerald, 2013) However, some PCPs do not adhere to or
use the recommended evidence-based practice (EBP) guidelines as outlined by the ADA
for the testing and frequency intervals of obtaining the A1C measurements (Egbunike &
Gerald, 2013).
Optimal outcomes of quality care in the DM patient require the timely testing of
A1C in order to prevent poor diabetes management or control. Patients with poor or
uncontrolled DM are at increased risk for organ damage and other complications,
including macrovascular and microvascular complications (Egbunike & Gerald, 2013).
DM patients with the macrovascular and microvascular complications are at a greater risk
for glaucoma, neuropathy pain, peripheral amputations, and nonhealing wounds
(Egbunike & Gerard, 2013).
The standardization of the A1C measurements in recent years has been endorsed
by the World Health Organization as a diagnostic criterion for the diagnosing and
management of diabetes. In 2009, the ADA supported and recommended the use of
A1C, along with many other major professional diabetes associations. The World Health
Organization and ADA have recognized the advantages of using the A1C since no fasting
is required by the patients with less measurement variability than levels of plasma
glucose (Smith, 2012).
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Implications for Social Change
This DNP proposal is significant for social change because EPB literature has confirmed
that diabetes is a health problem for people in rural WV. Appalachian rural clinic PCPs
currently do not have standard tools in place to monitor the frequency of A1C testing for
the patient at risk or who already has diabetes Type 2. The ADA guideline literature has
indicated that following the clinical practice guidelines for the frequency of A1C testing
helps to provide the diabetic patient with safe and effective care with optimal outcomes.
The social change will improve and impact the individuals in the Appalachian patient
population by helping to control diabetes by the PCP use of the ADA A1C clinical
practice guidelines.
Definition of Key Terms
The definition of key terms that are often used in duplication and throughout this
study include the following:
American Diabetes Association (ADA): A professional association whose goal is
to educate and help those who are affected by the consequences of diabetes, provides
objectives and credible information about diabetes, and funds research to manage,
prevent, cure, and deliver services to communities (ADA, 2013).
Appalachian region: The Appalachian Mountain Chain and rural areas, including
the entire state of West Virginia (The Appalachian Community, 2012).
Diabetes mellitus (DM) or Diabetes: A condition (hyperglycemia) that results
because the body is no longer able to use blood glucose for energy. Type 2 diabetes
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occurs when the pancreas is unable to use the insulin correctly or not enough insulin is
made (ADA, 2013).
Glycosylated hemoglobin A1C (A1C): A lab test that measures the previous 90 to
120-day (2 to 3 months) average of the glucose amount that has contact or sticks with the
red blood cell hemoglobin molecules (ADA, 2013).
Assumptions and Limitations
In this project, there are more limitations than assumptions. I assumed that
providers want to do what is right or is considered to be best for the patients they care for
in clinical practice (see Shaefer, 2006). Another assumption is that educating the
providers will change practice, and changing practice will improve health. I also
assumed that the patient wishes to become involved in his/her care for the improvement
of his or her health.
Limitations for the use of clinical practice guidelines that can occur in the rural
clinics are that the provider incorrectly ordered the A1C test. Overuse of testing and
resources adds additional unnecessary cost to the patient and health care system. The
standards are patients with A1C values that were ≤ 7%; according to the ADA (2013)
clinical practice guidelines, the A1C does not need to be ordered again for a year.
If the A1C testing is done more often than necessary, it is evident that PCPs need
support in the learning process and continued education. The geographical area where
the rural clinic was located can be a limitation to the frequency and PCP adherence to
following the EBP ADA guidelines. The area has harsh weather during the winter

11
season; snow, cold, and ice can be a reason the patient may not be able to make it to their
provider for scheduled appointments or have A1C testing completed in a timely manner.
Lastly, a limitation that could occur in the rural PCP is the tracking of A1C
testing. The rural clinics have electronic health records (EHR); however, not all
documents are typed in a timely manner. The progress note is scanned into the EHR
directly after the provider visit. However, the provider has to take the time later to get it
typed; there are times because of the increase in patient load that the notes do not get
typed for several weeks. Therefore, the tracking system cannot be used correctly to
monitor the frequency of A1C testing.
Summary
In summary, the Appalachian rural clinic PCPs currently do not have standard
tools in place to monitor the frequency of A1C testing for patients at risk or who already
have dabetes Type 2. Testing for the A1C by PCPs in clinical practice is often not
completed during the patients routine office visits. The ADA and other EBP literature
has indicated that following the clinical practice guidelines for the frequency of A1C
testing helps to provide the diabetic patient with safe and effective care with optimal
outcomes. Diabetes is an issue in the rural community and in WV. Having adequate
healthcare and diabetic management is critical to providing high-quality diabetes care to
the Appalachian rural population.
The practice problem for the DNP staff education project is that some PCPs need
to be made aware and knowledge and understanding about the ADA guidelines. The PCP
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practice problems can be a result of self-efficacy and lack of confidence in ability,
leading to clinical inertia (Shaefer, 2006).
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Section 2: Background and Context
Introduction
I conducted a literature review and comprehensive search to obtain EBP literature
and studies related to the monitoring of the provider frequency for A1C testing and
frequency in the Appalachian rural clinics (see Burns & Grove, 2009). The literature
review was also necessary in the search for clinical practice ADA guidelines, the selfefficacy and ADA guideline agreement, and the ADA clinical practice guideline
adoption. In this section, I also cover the theoretical framework, and EBP model using
scholarly data that provide a foundation for the development of the plan for patient
management of DM.
The search strategy included a systematic approach consisting of a detailed
search, including Publisher Medline, Nursing & Applied Health Sciences, Cumulative
Index to Nursing and Allied Health, Ovid Nursing Journals Full Text, and Medical
Literature Analysis and Retrieval System Online. Other online searches were conducted
through Mozilla Firefox Google, where I found EBP material, data, and information such
as but not limited to the ADA, Healthy People 2020, United States National Library of
Medicine, and WV Department of Health and Human Resources.
I focused on EBP guidelines and studies written in the English language from
early 2000 to 2014, with a small number of articles selected in the search process being
prior to the year 2000 because no recent information and literature were comparable. The
search produced 496 articles, dissertations, meta-analyses, systematic reviews, peerreviewed articles, comparison studies, randomized control trials, cross-sectional analyses,
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experimental research studies, and journal articles with guidelines and models. A final
number of research articles used in the DNP pilot project was 16. The search words used
for the database search were glycosylated hemoglobin A1C, Hgb A1C, A1C, diabetes
mellitus, diabetes, rural diabetes care, diabetes outcomes, and frequency of A1C testing.
Literature Review
ADA Guideline Awareness and Adherence
Physician and provider adherence are crucial in interpreting recommendations
into improved patient outcomes (Cabana et al, 1999). The National Clearinghouse of
Guidelines provides sources to assist health care providers with guidelines on many
clinical issues. The EBP database is available to the public for free (U.S. Department of
Health and Human Services AHRQ, 2014).
The patients where adherence was followed according to the ADA guidelines for
the frequency of monitoring the A1C in rural PCP had better A1C diabetes control that
those where the ADA guidelines were not followed (Parcero, Yaeger & Bienkowski,
2011). This provides strong empirical support in adherence of following the A1C
frequency to the ADA guideline (Parcero et al, 2011). The monitoring and measurement
of glycemic control are considered a basis for management for patients with DM. Having
the A1C lab results at the point of care during patient visits results in an increase in the
use in therapy and an improvement in the patient’s glycemic control (Neumiller et al.,
2010).
Interventions by physicians in clinical practice including feedback about glycemic
control monitoring of A1C has led to improved diabetic patient care in Medicare
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beneficiaries (McClellan, et al., 2003). In general, patients in rural communities need
greater attention to diabetes care. The ADA recommendations are for the A1C testing to
be completed every 3 months. In this study, I focused on physicians, physician assistants,
and nurse practitioners, finding that PCPs are slow to accept standards of care for
diabetes care and management (Glasser, Peters, Warner, Burkholder, Sharp, McGee,
2010). In 2011, Parcero, Neumiller, McClellan, and Glasser concluded that the lack of
awareness or knowledge about the guidelines and its objectives has resulted in low
adherence to the frequency of A1C testing.
ADA Guideline Agreement and Self-Efficacy
Use of the ADA guidelines by the PCP can help to increase glycemic control; by
doing this, the incidence of comorbidities related to DM Type 2 is reduced (Schaefer,
2006). A PCP’s lack of self-efficacy leads to clinical inertia. Clinical inertia is described
as a provider's unwillingness or inability to intensify medication treatment in patients
whose glycemic control is nontherapeutic (Schaefer, 2006).
The physician or provider finds patient poor adherence to be because of having
low self-efficacy. Low adherence is due to the lack of preparation or lack of confidence
in ability. Researchers have suggested that the barrier is associated with counseling and
preventive health education, suggesting that poor self-efficacy may be a common barrier
to adherence for EBP health care and management guidelines (Cabana et al., 1999). Selfefficacy is the confidence and belief that a person can perform a behavior; it also impacts
whether the behavior will be started and continued in spite of poor outcomes (Cabana et
al., 1999). A low self-efficacy that is due to a lack clinical inertia is considered to be a
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problem that occurs commonly by providers when managing illnesses that did not present
in a systematic way (Cabana et al., 1999). Clinical inertia is caused by the recognition of
a problem, not necessarily by the failure to act on the problem. Some providers may be
quick to lay the blame on the patient’s noncompliance; however, researchers have shown
that clinical inertia is the problem of the physician and provider delivery system, along
with the health care system that did not take appropriate action for the benefit of that
patient(Cabana et al., 1999). Clinical inertia can be applied to silent chronic diseases such
as diabetes, hypertension, and hyperlipidemia.
In diabetes, some providers have failed to screen, diagnose, manage, or treat a
patient with diabetes at an acceptable A1C level of < 7%. The failure has been in spite of
the 2011 CDC, current data that show that diabetes is an epidemic expanding problem in
the United States. Society is well aware of DM with print media, such as popular
magazines and television advertisements concerning DM (Shafer, 2006).
Clinical inertia is directly recognized as a lack of self-efficacy because of the
provider having an attitude barrier. The provider having a casual awareness of the
guideline recommendations does not guarantee the familiarity of A1C guidelines and the
actual ability to use them correctly (Cabana et al., 1999). The providers in rural PCPs
with adherence to the ADA guidelines for frequency of monitoring hemoglobin A1C had
patients with better glycemic control of diabetes than those who did not; therefore, this
provides to be strong empirical support for the guidelines (Parcero et al, 2011). In order
to end clinical inertia, the PCP barrier of awareness requires both guideline knowledge
and a change in provider behavior (Vigersky, 2011).
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ADA Guideline Adoption
Full adoption of the clinical guidelines requires that the PCPs agree with the
guidelines (Massey, Appel, Buchanan, Cherrington, 2010). As part of this adoption of
the EBP ADA guideline, the PCP should acknowledge the A1C as the standard method
of monitoring diabetes, thus increasing the patient's glycemic control (Parcero, 2011).
The PCP requires both guideline knowledge and a change in provider behavior. PCPs
use the A1C testing and monitoring to educate the patient, make changes in the patient's
diet, provide recommendations for exercise, and adjust the medication regimen
(Vigersky, 2011).
The PCPs that understand the ADA clinical practice guidelines are likely to be
involved in different approaches to reach their patient population in the community, such
EBP ADA guidelines regarding the frequency of A1C monitoring and testing in primary
care setting (ADA, 2013). In addition, there is an increase in the patient’s mortality and
morbidity with poor control of glycemic levels (ADA, 2013).
Theoretical Framework/ Evidence-Based Practice Model
The DNP Essential I of nursing practice examines nursing theory and science that
focus on the concepts to strengthen and support the DNP practice (Zaccagnini & White,
2011). EBP models, and theoretical framework are used by the DNP to help in the
organization and integration of nursing knowledge, practice, and science. Theories and
models can also offer a systematic way to clarify the parameters of nursing practice to
benefit the DNP project to improve compliance of A1C testing following the EBP
clinical ADA guidelines (Zaccagnini & White, 2011). The project requires a
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strengthening in clinical practice by the health care PCP in the rural clinic. To help in the
change process of clinical practice using the ADA clinical practice guidelines will be the
use of Lewin’s planned change theory and the plan-do-study-act (PDSA) improvement
model
Theoretical Framework
Today’s healthcare is in a constant state of change. With change, come feelings
of anxiety, uncertainty, and upheaval (McEwen & Wills, 2011). The theory applies to the
DNP project for a smooth transition of the change in clinical practice for health
promotion and disease prevention is the Lewin’s planned change theory. A force of
change according to Lewin is the driving force (McEwen & Wills, 2011). The DNP can
be part of that driving force to help in the disease prevention and management of
diabetes; thus, improving the overall outcome of the patient mortality and morbidity in a
rural clinic. To be successful in the planned changed are unfreezing, movement, and
refreezing. (McEwen & Wills, 2011).
There are three phases of Lewin’s planned change theory for the rural clinic:
1.

Unfreezing – involves meeting with the primary care providers to discuss a
need for the change in clinical practice to follow the ADA guidelines for
frequency of A1C testing in the diabetic patient to alleviate any stress or
uneasiness about the process.

2.

Movement – Prior to the initiation of change, research of diabetic patient
population, education materials, ADA guidelines for use by for the primary
care providers in the rural clinic, and feasibility of the change in practice.
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3.

Refreezing – Stabilization occurs, and the planned integration into primary
care provider has initiated and uses the ADA clinical practice guidelines as
part of their daily practice for monitoring of the A1C to improve glycemic
control in the diabetic patienets in the rural clinic.
(McEwen & Wills, 2011)

Evidence-Based Practice Model
Along with the Lewin’s planned change theory; PDSA improvement model will
be used by the DNP in the clinical practice change process for a smooth transition of all
involved. A model that can be utilized in the rural clinic practice setting is the PDSA
model for improvement. The PDSA model in particular was chosen because it can be
simply used as a guide by the DNP to incorporate a systematic process for change to EBP
(Pipe, 2007). The model’s focus is for change to the EBP by using the PDSA (White &
Dudley-Brown, 2012).
The PDSA steps are as follows: Plan - the change to be implemented or tested
involves gathering baseline data. This stage is to test for quality improvement. Do carry out the project on a reduced scale and change the processes as problems occur. At
this stage, documentation of the process occurs along with the integration of data
analysis. Study - set aside sufficient time to analyze the data. Act - analyze the data,
plan revision, and restart the PDSA cycle (Institute for Healthcare Improvement, 2011).
Plan-Do-Study-Act Method
The appropriate method for implementation is the use of the PDSA method for
the project in the rural clinic health care setting (Institute for Healthcare Improvement,
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2011). The PDSA cycle identifies specific measures of change; then, test change in the
actual work setting (planning, trying, observing, and acting) on the actual results about
what is learned (Institute for Healthcare Improvement, 2011). The aim is to refine the
improvement of the project by using the PDSA cycle. This is accomplished by
advancing through the PDSA cycles numerous times eventually having the ability to
apply the implementation of change on a broader scale basis throughout a larger
healthcare system (Institute for Healthcare Improvement, 2011).
Summary
Change is important to improve patient outcomes in the current healthcare system
(Hykas & Harvey, 2010). Coming up with new solutions by using research and EBP,
then integrating the new knowledge into clinical practice is part of the leadership role
used by the DNP nurse (Hykas & Harvey, 2010). The comprehensive literature search
completed for the provider A1C frequency testing in the rural clinic setting program
design came from different sources such as the Walden University library and other
reliable online internet sources. EBP used for the DNP project development came from
the ADA clinical practice guidelines. The EBP theoretical framework and model
included the Lewin’s planned change theory and thepPlan-do-study-act improvement
model and is applied to the EBP DNP project transition of the change in the Appalachian
rural clinics.
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Section 3: Collection and Analysis of Evidence
Introduction
The purpose of this section is to explain an improvement plan designed for a
future full scale long term organizational process and evaluation plan. I discuss the
project design and methods, the setting and participants with permission and protection,
and an overview of the project design and evaluation plan using the PDSA. The DNP
project is divided into five stages that represent portions of the PDSA cycle for future use
at the Appalachian clinic.
Step 1 is plan. I assumed a leadership role in this project by educating the PCP
through a Power Point presentation (Appendix A) on the importance of obtaining the
A1C in the Appalachian rural clinics. I also reviewed all the objectives of the DNP
project with the participants. I trained the head family nurse practitioner (FNP) on how
to follow up with the administration of the pretest (Appendix B) to the providers; if
needed, the head FNP will review the material again in the educational Power Point
presentation (Appendix A).
Step 2 is do. The trained head FNP followed up with each of the providers
participating to see if objectives were followed. If needed, there was remediation with a
review of the educational Power Point (Appendix A) with objectives and a review of
clinical inertia.
Step 3 is study. The head FNP administered the posttest (Appendix B) with the
participating providers, collected all the data, analyzed the qualitative data, identified the
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common themes, and prepared the final report that will be completed semiannually by the
head provider in the Appalachian rural clinics.
Step 5 is act. Issued the final report to the members of the Appalachian rural clinic
participants, members, and the administration. To keep me informed and involved, a
report of the final data and outcome will be presented either via phone, personal visit, or
e-mail.
Design of Staff Education
The purpose of the project was to increase the knowledge of the PCPs regarding
the ADA clinical practice guidelines following an educational intervention and to assess
compliance of use of the guidelines among providers. Specifically, each provider took a
prereview test (Appendix B) to determine the level of baseline knowledge, behavioral
barriers, and self-efficacy using the ADA clinical practice guidelines for A1C
monitoring. Then, each provider viewed the Power Point presentation (Appendix A) to
introduce the ADA clinical practice guidelines for A1C monitoring. After the review, the
providers were asked to complete a posttest (Appendix B) to determine if an increase in
knowledge has occurred.
Project Setting and Participants’ Staff Education
The setting was an Appalachian rural clinic privately owned by a medical doctor
in family practice in rural WV. The population and sample in the study included six
medical doctors, two doctors of osteopathic medicine, 13 master’s level prepared FNPs,
and 11 master’s level prepared physician assistants (PA), for a total of 32 potential
participants. Permission was granted to access the EHR of each PCP that agreed to
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participate in the DNP project. As providers are hired, the head FNP will repeat the
process and steps of the PDSA cycle, adding to the semiannual report.
The Health Insurance Portability and Accountability Act law states that all patient
data are protected; therefore, no patient data will be divulged before, during, or after the
DNP project concerning the adherence about the frequency of A1C testing and
monitoring of the diabetic patients in the Appalachian rural clinic (U.S. Department of
Health and Human Services, 2003).
Data Collection of Staff Education
In order to determine an increase in knowledge among the providers, each
provider completed a pencil-paper pre- and post-test survey (Appendix B) with the use of
a personalized identifier. The pre- and post-test surveys contained nine questions, with
Questions 1 to 4 related to knowledge of the ADA A1C National Guidelines. Questions
5 to 9 addressed PCP thoughts about the usefulness of following the ADA clinical
practice guidelines in ordering. The pre- and post-test surveys were identical in nature,
and no identifiable information was collected.
Data Analysis of Staff Education
Data from both the pre- and post-test surveys and from the retrospective chart
review were entered into an Excel spreadsheet. The data from the pre- and post-test
surveys were analyzed using descriptive and inferential statistics to determine if there
was a difference in the number of questions answered correctly in the pre- and post-test
surveys.
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Budget and Timeline
The budget and financial analysis for improving provider A1C testing frequency
adherence to the ADA clinical practice guidelines did not require many resources/ much
funding to initiate the DNP project. The rural clinic owner covered the cost of resources
for the pilot project. The potential PCP participants have already declined an
honorarium.
For the proposed practice change to be effective and successful in the
Appalachian rural clinic, there must be materials to present to the providers about A1C
testing frequency and the guidelines, space for the meeting, paper to print off the
education action plan booklet for the providers, use of a scanner and copier, and
employee time. The staff in the rural clinic were provided lunch with an in-kind clinic
donation from the owner on the provider informative training days. The direct cost for
the DNP project ADA guideline on A1C frequency and testing training days for the
providers totaled $2,931.96.
The timeline for the DNP project was created to follow the progression of the
DNP project from beginning to end. The prevention and control of DM is accomplished
when the PCP adheres to the ADA clinical practice guidelines for the frequency of A1C
testing, thus increasing the quality of life of the patient population. Success of the project
depended on feedback from providers. The minimal startup cost of the project along with
the funding assistance of the clinic administrator/owner equals saved lives and the cost to
the target group.
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Summary
The DNP project is critical for sustainability as it studies one of the most
profound diseases in our nation today. Designing and managing problems of this
magnitude are important not only for this underserved health population but for so many
others who are still not identified or being served adequately (Smith, 2011). Monitoring
of the A1C levels helps to reduce the incidence of health care costs and comorbidities in
the Appalachian rural clinic patient population. The purpose of this project was the
development of quality improvement use of ADA clinical practice guidelines with a
focus on the frequency of A1C testing for the implementation by the provider. The
practice change based on EBP can be successful in the rural clinic, particularly if active
collaboration occurs with all parties involved working together in the direction of the
same common goal.
IRB: 07-12-18-0408605
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Section 4: Findings and Recommendations
Introduction
The purpose of this DNP project was to provide staff education and evaluate the
measure of knowledge of the PCP in an Appalachian rural clinic located in WV. The
DNP project topic and questions regarded the recommended ADA guidelines for A1C.
PCP education was of importance for a smooth transition of change in a clinical practice
setting among the PCP for health promotion and disease prevention of DM. A force of
change, according to Lewin in 2011, was the driving force to improve the overall
outcome of the patient mortality and morbidity in an Appalachian rural clinic in WV by
educating the PCP on the ADA guidelines for A1C monitoring and testing. The DNP
objective for the staff education was to increase the knowledge of the ADA guidelines for
A1C monitoring and testing among PCP.
Optimal outcomes of quality care in the DM patient require the timely testing of
A1C to prevent poor diabetic management or control. The patient with poor or
uncontrolled DM is at an increased risk for organ damage. DM patients are at a greater
risk, leading to glaucoma, neuropathy pain, peripheral amputations, and nonhealing
wounds. Following the ADA guidelines, routine monitoring of glycemic control using
A1C by providers in clinic practice is often not completed during routine office visits
(Egbunike & Gerard, 2013) . Eighty percent of patients in the first year do not have
testing for A1C measurements (Egbunike & Gerard, 2013). Therefore, the patient
population can be impacted by PCP’s use of the tools provided for achieving goals that
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addressed an increase in their knowledge of the ADA guidelines or frequency of A1C
monitoring and testing.
Tools used for educating the PCP were a self-developed Power Point presentation
on the importance of obtaining the A1C and a pre/post survey. A presurvey and
postsurvey with the participating providers determined the level of baseline knowledge,
behavioral barriers, and self-efficacy using the ADA guidelines for A1C monitoring. The
pre- and post- survey asked nine questions identical in nature; Questions 1 to 4 related to
knowledge of the ADA guidelines, and Questions 5 to 9 examined the PCP’s thoughts
about the usefulness of the clinical ADA guidelines. The rating scale for Questions 1 to 9
included highly disagree, somewhat disagree, neither agree nor disagree, somewhat
agree, and highly agree.
Each PCP participant took a presurvey to determine the baseline level of
knowledge using the ADA guidelines for A1C monitoring and testing. The PCP then
viewed the A1C education component of A1C according to the ADA practice guidelines
and then was given the opportunity to ask questions to make sure the goals were
understood. Lastly, at the conclusion of the Power Point, each PCP completed the
postsurvey, determining if there was an increase in PCP awareness and understanding of
the ADA guidelines for A1C testing.
Discussion of Findings
Demographics
The PCP participants in the Appalachian rural clinic comprised of medical
doctors, doctors of osteopathic medicine, physician assistants, and FNPs, for a total of 32
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potential sample pool PCP participants. Out of the 32 volunteers to participate in the
DNP project, a total of 12 pre/post surveys were completed and returned. The total PCP
completion rate was 38%.
A review of the surveys, pre/post survey Questions 1 to 4 pertained to the
knowledge of the ADA guidelines A1C testing frequency; Questions 5 to 9 indicated the
PCP attitude about using the guidelines. For Question 1, 92% of the PCP participants
presurvey answered the rating of highly agree with being familiar with the ADA
guidelines pertaining to the frequency of A1C monitoring and testing in the patients with
diabetes; however, in the postsurvey, they answered 100% highly agree on the same
question. For Question 2, 67% of the PCP participants answered highly agree on the
presurvey for offering safe, effective, quality care; on the postsurvey of that same
question, there was a rating of 100% highly agree.
In the last question of the pre/post surveys, each PCP was given the chance to
identify and describe any barriers that existed in their clinical practice to measure A1C in
the diabetic patients according to the ADA guidelines. The behaviors reported and
identified that hindered their patients to have the A1C included the following:
1. Lack of provider or nursing knowledge of guidelines.
2. Distance the patient has to travel to be seen (rural setting).
3. Delayed lab results (requiring extra follow-up appointment for patient).
4. Patient’s failure to keep appointment due to forgetfulness.
5. Bad weather or lack of transportation cause canceled appointments.
6. Patients losing their lab order after A1C is ordered (lab location barrier).
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7. Patient is noncompliant or patient knows their A1C will be elevated.
8. Patient simply does not want to come to appointment because it might result in
added medications or a change in lifestyle.
All of the 12 PCPs in the Appalachian rural clinic who responded and returned the
post surveys for education and knowledge of A1C monitoring agreed that they are now
more aware of their ordering and monitoring practices. Responses to the Appalachian
rural clinic PCP presurvey is shown in Appendix C. PCP postsurvey results are found in
Appendix D. Also, Appendix E: Pie chart for comparison of presurvey of total
responses and Appendix F: Pie chart for comparison of postsurvey of total responses
Implications
Implications on Practice, Future Research, and Social Change
Evidence-based literature has confirmed that DM is a health problem for the
patient population in the Appalachian region; therefore, PCP education is of significant
importance. ADA guideline literature indicated that following the ADA guidelines in
clinical practice for the frequency of A1C monitoring helped provide the PCP with
knowledge needed for diabetic patients. Education and training need to be continued
with new PCP hires for the success of future research. A potential positive social change
is that the patient’s quality of life can increase by decreasing mortality and morbidity of
potential negative outcomes of multisystem complications that could occur as a result of
having DM.
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Limitations
The PCP education survey pre/post evaluations were limited due to less than
expected PCP participation of postsurvey completion. The initial number of PCP
volunteer participation in the Appalachian rural clinic in the education was 32. Various
factors were reported that prevented a greater PCP participation, including previous
obligations, meetings, illness, vacations, and other unreported unexpected events. A total
of 20 PCPs attended the Power Point presentation; however, only 12 completed and
returned the pre/post surveys.
Strengths
Data from the surveys obtained the PCP perceptions of the educational power
point presentation on the A1C education component monitoring according to the ADA
practicing clinical guidelines. All PCP answered the intent was to offer and provide
effective, safe, and quality of care. The group of PCPs answered 100% on the post
survey that they were familiar with the ADA guidelines concerning the frequency of A1C
monitoring of DM. No PCP participants answered on either the pre and post survey as
highly disagree. See Appendix G for the differences in presurvey and postsurvey
responses and Appendix H for the pre-post survey trends.
The same number of people responded with highly disagree or somewhat
disagree in the presurvey and in the postsurvey. There were nine fewer responses of
neither agree nor disagree and 13 fewer responses of somewhat agree in the postsurvey
than in the presurvey. There were 22 more responses of highly agreed with questions in
the postsurvey than in the presurvey.
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Summary
The DNP project and PCP education in the Appalachian rural clinic is for
sustainability as it used one of the most profound diseases in the nation today for the
study. PCP education on the monitoring of the A1C levels lead to help reduce
comorbidities and mortality in the patient population. A presurvey, Power Point, and
postsurvey was used as a tool in the data collection of 12 PCPs in the rural clinic.
Data from the surveys obtained the PCP perceptions of the educational power
point presentation on the A1C education component monitoring according to the ADA
practicing clinical guidelines. All PCP answered the intent was to offer and provide
effective, safe, and quality of care. 100% answered on the postsurvey that they were
familiar with the ADA guidelines concerning the frequency of A1C monitoring of DM.
None of the PCP participants answered any question on either the pre or post survey as
highly disagree.
Total results indicate an overall improvement in total responses, the highly agree
PCP presurvey total responses from all the question was 48%, with an increase on the
PCP post survey to 68%. PCP participation in the educational proponent for A1C
monitoring and testing provided to be a beneficial outcome in the Appalachian rural
clinic. The increase in PCP knowledge of ADA clinical practice guidelines for A1C
monitoring can only lead to improved patient outcomes and quality of care.
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Section 5: Dissemination Plan
Self-Analysis as a Scholar
The development of this DNP project has greatly increased my skills in
implementing and developing a PCP education program using clinical scholarship and
writing. The dream of obtaining a terminal doctorate degree has been a goal of mine
during most of my nursing career, first as a registered nurse and now as a nurse
practitioner, which has spanned over 20+ years. I will be able to reach my goal and
dreams with the completion of this DNP project. The role of the DNP has increased my
awareness and importance of research of patient problems daily in clinical practice,
especially scholarly articles.
Self-Analysis as a Practitioner
This DNP project has helped me to gain increased skills and knowledge as a
family nurse practitioner and educator. I have taught nursing in WV higher education in
seat and online at private colleges, with plans to teach online nursing courses in the near
future. I have several years of experience in family practice and now work in the
specialty area of palliative care and chronic illness. Having a DNP degree leads to an
augmented credibility to each of my roles in the future as an educator and currently in
clinical practice.
Self-Analysis as Project Developer
During the course of the development of this DNP project and PCP education, I
have become passionate about researching topics in clinical practice. The topics include
not only DM but other chronic illness as well, in the patients I care for daily. Working
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many years in family practice and now in palliative care and chronic illness in the
Appalachian region made me realize even more how important research can be. Along
with research, completion of the DNP project and doctoral degree have made me aware
of the significance of keeping the PCP informed through education. I feel more selfconfident and comfortable in the area of research and look forward to studies yet to come.
The development of the DNP project and PCP education have given me more awareness
and objectivity as well as the bonus of achieving my nursing dreams and goal.
Summary
The evaluation of self as a scholar, practitioner, and project developer has been a
timely and trying process, a journey I will not regret. During this process, I have grown
in all the areas in the evaluation of self. In the area of scholar, there has been an increase
in my skills in implementing and developing a PCP education program using clinical
scholarship and writing. In the process of all the years, my dream of obtaining a terminal
doctorate degree is becoming reality. In the area of practitioner, the DNP project has
helped me increase skills and knowledge as a family nurse practitioner and educator. As
a DNP project developer, I am passionate about researching topics in clinical practice.
Working many years in family practice and now in palliative care and chronic illness in
the Appalachian region made me realize even more how important research can be. The
DNP project and doctoral degree made me feel more self-confident and comfortable in
the area of research, and I look forward to studies yet to come.
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Appendix A: A1C Education Component
Slide 1
A1C Education Component
Quality Improvement & PCP Monitoring of A1C according to the American
Diabetes Association Practice Guidelines
Susan Simmons MSN, FNP-C
Slide 2
A1C
The 2013 ADA Clinical Practice Guidelines for Medical Practice.
A1C monitoring and testing is considered to be “Gold Standard” in Diabetes
Mellitus management and care.
➢ Who?
➢ Why?
➢ When?

Slide 3
Who?
Why? When?
➢ Who? The 2013 ADA Practice Guidelines and Standards of Care advises all DM
patients be screened using A1C for management and treatment.
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➢ Why? Research and EBP determined that strict glucose control lessened the risk
of associated complications from DM in renal, cardiovascular, ophthalmologic,
and neurological systems.
➢ When? According to the ADA Practice Guidelines recommend that A1C
monitoring and testing be done every 6 months (semi-annually) for patients that
are stable with values < 7; every 4 months (quarterly) for patients A1C > 7; every
3 months after a change in treatment for assessment of effectiveness of changed
and/or new treatment.

Slide 4
Who?
➢ General Patient Population – At risk for DM
➢ DM Type I & II Adult (18 – 65)

Slide 5
Why?
➢ Research study over a 10-year period performed by the NIH of over 1,440
participants in the study with Type I DM. The research study concluded that
intensive glucose control decreases the risk of renal (50%), cardiovascular (57%),
ophthalmologic (70%), and neurologic (60%) complications.
➢ Research study over a 20-year period (1977-1997) performed by the UK
Prospective DM study by Oxford University of over 5,000 participants. The
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research study concluded that intensive control over glucose decreases all
microvascular diseases (24%); nonfatal CVA, MI (57%); Fatal MI (33%).

Slide 6
Why?
➢ ≥Patients with an elevation of A1C levels have an increased risk for opportunistic
disease and infection.
➢ Keep in mind – if the A1C blood sugar ≥ 7%; the endothelial tissues of the renal,
cardiovascular, ophthalmologic, and neurologic systems are under attack and
higher risk for damage.

Slide 7
Why?
➢ A1C of 7% = 154 Daily Average Blood Sugar ranges (123-185) (ADA, 2010)
➢ A1C of 8% = 183 Daily Average Blood Sugar ranges (147-217) (ADA, 2010)
➢ A1C of 9% = 212 Daily Average Blood Sugar ranges (170-249) (ADA, 2010)

Slide 8
When?
➢ PCP additional reasons to order A1C in the patient with DM
➢ Non-Healing Wound
➢ Vision Changes
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➢ Fungal Infections (Candida)
➢ Signs/Symptoms of Neuropathy
➢ Recurrent UTI’s
➢ Recurrent Sinusitis
➢ Elevated BP
➢ Fracture
➢ Skin Infection (styes, boils, carbuncles, folliculitis, and, paronychia)

Slide 9
What?
➢ What does this suggest for the patients?
➢ End clinical inertia by having a current A1C
➢ PCP recognize there is a problem with clinical inertia (failure to act)
➢ PCP deliberately show a different behavior from the clinical inertia when
unsure of their treatment options/choices, or does not know when a
changed treatment is required and/or needed, or when questioning patient
adherence to the recommended treatment options.

Slide 10
Ending Clinical Inertia
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➢ Keep in Mind
➢ Remember:
➢ If the patients A1C is 7% = 154 Daily Average Blood Sugar ranges
123-185.
➢ If the patients A1C is 8% = 183 Daily Average Blood Sugar ranges
147-217.
➢ If the patients A1C is 9% = 212 Daily Average Blood Sugar ranges
170-249.

Slide 11
A1C Tip Sheet
➢ Patients with DM comes into the rural clinic
➢ Is there an up to date or current A1C in the electronic health record?
➢ If no current A1C, order and A1C.
➢ If the patient A1C results is < 7%; order another A1C in 6 months.
➢ If the patient A1C result is more than 7%; adjust DM regimen, then re-order in 3
months.
➢ If yes, and is <7%; the patient is therapeutic, re-order another A1C in 6 months.

Slide 12
Any Questions?
Thank you for being a participant!
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Slide 13
Reference
American Diabetes Association (2013). American Diabetes
Association standard
of medical care practice guideline 2013.
Diabetes, 36 (Supp 1 S11-S66 doi:
10,2337/dc13=S11 Retrieved from: http://care.diabetes
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Appendix B: Pre/Post ADA Guidline (A1C) Study Test
Question 1- 9

Highly

Somewhat Neither

Disagree Disagree

Agree,

Somewhat

Highly

Agree

Agree

Nor
1

2

Disagree
3

1.I am familiar with the
American
Diabetes Association
(ADA) guidelines
concerning the frequency
of A1C testing in diabetes
mellitus (DM) treatment
and management.
2. I personally offer safe,
effective, and quality care.
3. I personally like to use
national clinical practice
ADA guidelines to make
treatment decisions.
4. I personally believe the
clinical practice ADA
national guidelines are
helpful when making
treatment plans.
5. I agree that having a
current A1C is helpful in
the development for

4

5
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treatment decisions making
for my DM patient
population.
6. I feel it is important to
know a DM patient's A1C
when I make treatment
options.
7. I feel in the future,
utilizing a current A1C will
be an integral part of my
clinical treatment decisions.
8. I follow the guidelines
for frequency of assessing
the A1C in patients with
"unstable" DM? (A1C ≥
7%)
9. I follow the frequency of
assessing the A1C in
patients with stable DM?
(A1C ≤ 6.9)
10. Describe any barriers that may exist in your clinical practice to measure A1C for
your Type II DM patients.
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Appendix C: Primary Care Provider Pretest Survey Results
Question Highly

Somewhat Neither

Disagree Disagree

Agree Nor

Somewhat Highly
Agree

Agree

Disagree
1.

1

2.

11
2

10

3.

2

4

6

4.

1

7

4

5.

1

5

6

6.

1

4

7

8

4

4

5

3

3

6

1

7.
8.
2

10. Please use the space below to answer this question: Describe any
difficulties that occurred in your clinical practice to measure A1C for
your DM Type 2 patients. Example: PCP non-adherence to guidelines
is due to a cognitive difference of awareness, agreement, and adoption

- Distance the patient has to travel to be seen (rural setting)
- Delayed lab results (requiring extra follow-up appointment for
patient)
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- Lack of provider or nursing staff knowledge of guidelines
- Patient fails to keep appointment due to forgetfulness
- Bad weather or lack of transportation cause cancelled appointments
- Patients losing their lab order after A1C is ordered (lab location
barrier)
- Patient simply doesn’t want to have blood drawn.
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Appendix D: Primary Care Provider Posttest Survey Results
Question Highly

Somewhat Neither

Disagree Disagree

Agree Nor

Somewhat Highly
Agree

Agree

Disagree
1.

12

2.

12

3.

4

8

4.

3

9

5.

2

10

3

8

4

8

1

6

5

2

6

2

6.

1

7.
8.
9

2

10. Please use the space below to answer this question: Describe any
difficulties that occurred in your clinical practice to measure A1C for
your DM Type 2 patients.

Example: PCP non-adherence to

guidelines is due to a cognitive difference of awareness, agreement,
and adoption

- Distance the patient has to travel to be seen (rural setting)
- Delayed lab results (requiring extra follow-up appointment for
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patient)
- Patient fails to keep appointment due to forgetfulness
- Bad weather or lack of transportation cause cancelled appointments
- Patients losing their lab order after A1C is ordered (lab location
barrier)
- Patient is non-compliant or patient knows that A1C will be elevated
- Patient simply doesn’t want to have blood drawn.
- Patient doesn’t want to come to appointment because it might result
in added medications or a change in their lifestyle.
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Appendix E: Pie Chart for Comparison of Presurvey of Total Responses

Pie Chart for Comparison of Presurvey of Total Responses
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Appendix F: Pie Chart for Comparison of Postsurvey of Total Responses

Pie Chart for Comparison of Postsurvey of Total Responses
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Appendix G: Difference in Presurvey and Postsurvey Responses
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Appendix H: Pre/Post PCP Survey Trends Indicate an Improvement Post Survey

